ARAF
Basic information
Region (hg38): X:47561205-47571908
Previous symbols: [ "ARAF1" ]
Links
Phenotypes
GenCC
Source:
- diffuse lymphatic malformation (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARAF gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 21 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 2 | 3 |
Variants in ARAF
This is a list of pathogenic ClinVar variants found in the ARAF region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-47563004-G-A | not specified | Uncertain significance (Sep 29, 2023) | ||
X-47563013-C-T | not specified | Uncertain significance (May 29, 2024) | ||
X-47563219-C-T | Uncertain significance (Oct 12, 2023) | |||
X-47563255-C-T | Likely benign (Jan 01, 2023) | |||
X-47563271-G-C | not specified | Uncertain significance (Mar 31, 2024) | ||
X-47563305-G-T | not specified | Uncertain significance (Apr 15, 2024) | ||
X-47565010-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
X-47565130-A-G | not specified | Uncertain significance (Jul 06, 2022) | ||
X-47565132-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
X-47565277-T-C | not specified | Uncertain significance (Nov 09, 2021) | ||
X-47565291-A-T | not specified | Uncertain significance (Mar 20, 2023) | ||
X-47565308-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
X-47565335-C-A | not specified | Uncertain significance (Apr 23, 2024) | ||
X-47566652-C-T | not specified | Uncertain significance (Apr 06, 2023) | ||
X-47566680-C-G | not specified | Uncertain significance (Jul 15, 2021) | ||
X-47566721-T-G | Papillary renal cell carcinoma, sporadic • Lung adenocarcinoma • Malignant melanoma of skin | Likely pathogenic (May 31, 2016) | ||
X-47566722-C-G | Non-small cell lung carcinoma • Malignant melanoma of skin • Papillary renal cell carcinoma, sporadic • Lung adenocarcinoma | Likely pathogenic (May 31, 2016) | ||
X-47566722-C-T | Papillary renal cell carcinoma, sporadic • Lung adenocarcinoma • Malignant melanoma of skin | Likely pathogenic (May 31, 2016) | ||
X-47566731-A-G | not specified | Uncertain significance (Mar 14, 2023) | ||
X-47566737-A-G | not specified | Uncertain significance (May 23, 2024) | ||
X-47566777-C-G | not specified | Uncertain significance (Mar 01, 2023) | ||
X-47567043-G-T | not specified | Uncertain significance (Oct 12, 2021) | ||
X-47567066-C-G | not specified | Uncertain significance (Sep 16, 2021) | ||
X-47567113-C-T | Likely benign (Apr 01, 2023) | |||
X-47567236-C-G | not specified | Uncertain significance (Apr 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARAF | protein_coding | protein_coding | ENST00000377045 | 15 | 10792 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.963 | 0.0368 | 125643 | 3 | 4 | 125650 | 0.0000279 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.45 | 160 | 274 | 0.584 | 0.0000242 | 3934 |
Missense in Polyphen | 43 | 122.67 | 0.35052 | 1668 | ||
Synonymous | -0.433 | 120 | 114 | 1.05 | 0.0000103 | 1234 |
Loss of Function | 3.92 | 3 | 23.5 | 0.128 | 0.00000190 | 345 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000151 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000538 | 0.0000352 |
Middle Eastern | 0.000151 | 0.000109 |
South Asian | 0.0000531 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May also regulate the TOR signaling cascade. {ECO:0000269|PubMed:22609986}.;
- Pathway
- Non-small cell lung cancer - Homo sapiens (human);Chronic myeloid leukemia - Homo sapiens (human);Gastric cancer - Homo sapiens (human);Renal cell carcinoma - Homo sapiens (human);Long-term potentiation - Homo sapiens (human);Serotonergic synapse - Homo sapiens (human);Melanoma - Homo sapiens (human);Bladder cancer - Homo sapiens (human);Long-term depression - Homo sapiens (human);Acute myeloid leukemia - Homo sapiens (human);Breast cancer - Homo sapiens (human);ErbB signaling pathway - Homo sapiens (human);FoxO signaling pathway - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Glioma - Homo sapiens (human);Prostate cancer - Homo sapiens (human);Vascular smooth muscle contraction - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Hepatitis C - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Endometrial cancer - Homo sapiens (human);Colorectal cancer - Homo sapiens (human);Alcoholism - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Progesterone-mediated oocyte maturation - Homo sapiens (human);Vemurafenib Pathway, Pharmacodynamics;update your name in edit mode;Integrin-mediated Cell Adhesion;Signaling Pathways in Glioblastoma;Common Pathways Underlying Drug Addiction;ESC Pluripotency Pathways;Endometrial cancer;MET in type 1 papillary renal cell carcinoma;Chromosomal and microsatellite instability in colorectal cancer;MAPK Cascade;ErbB Signaling Pathway;MAP2K and MAPK activation;RAF activation;Disease;Signal Transduction;mapkinase signaling pathway;B cell receptor signaling;GPCR GroupI metabotropic glutamate receptor;GPCR signaling-G alpha q;CD4 T cell receptor signaling-ERK cascade;IGF signaling;FGF;IL-7 signaling;EGFR1;Negative regulation of MAPK pathway;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;JAK STAT pathway and regulation;NGF;EPO signaling;Signaling by RAS mutants;VEGF;Signaling by high-kinase activity BRAF mutants;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Diseases of signal transduction;CD4 T cell receptor signaling
(Consensus)
Recessive Scores
- pRec
- 0.353
Intolerance Scores
- loftool
- 0.172
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.36
Haploinsufficiency Scores
- pHI
- 0.964
- hipred
- Y
- hipred_score
- 0.831
- ghis
- 0.556
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.985
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Araf
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; digestive/alimentary phenotype; muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype;
Zebrafish Information Network
- Gene name
- araf
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- wholly dorsalized
Gene ontology
- Biological process
- MAPK cascade;cellular protein modification process;regulation of TOR signaling;regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process
- Cellular component
- cellular_component;mitochondrion;cytosol
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;metal ion binding